This engaging, enlightening panel discussion explores functional medicine strategies in immune conditions from the point of view of three experts with differing backgrounds and perspectives. Topics include fasting, psoriasis, medical cannabis and antibiotics in conditions such as scleroderma and rheumatoid arthritis.
In this joint presentation, Prof. Borody and Dr. Martin present a case of severe fistulizing Crohn’s disease which was healed with a combination of antibiotics, hyperbaric oxygen therapy and surgery. Powerpoint slides follow the video.
Featuring the world’s leading experts on this topic, Prof. Thomas Borody, Dr. William Chamberlin and Dr. Ira Shafran, this panel discusses antibiotic use in gastroenterology practice and answers audience questions.
November 27th marks the 2nd year of Human Para’s #GivingTuesday campaign. 2017 was a huge success, raising $9,254.26 to kick off the Crohn’s/MAP Testing Study.
Human Para’s #GivingTuesday2018 campaign is hoping to raise $5,000 to fund our next MAP research project. After the Berkeley conference and discussion by the Board, we are actively seeking partners for a PEDIATRIC testing study. Details will be released as soon as they are finalized, but be assured: ALL funds raised on #GivingTuesday will go directly to MAP research.
Dr. J. Todd Kuenstner reports preliminary results of the MAP/Crohn’s disease testing study, which found that viable MAP organisms were detected by phage assay in 54.6% of the 194 subjects in the study. The study will remain blinded until March 2019, when all testing is complete. Publication is expected in July 2019. Thank you to everyone who has made this study possible. To all of the Crohn’s and control subject participants, to the researchers who have donated their time and expertise, and to our Human Para community who have donated time and resources to this endeavor. A special note of thanks to Valerie Joly of Crohn’s Warrior Fights and the Denver, NC community for hosting a golf tournament which raised a whopping $22,678.32, and funded the majority of the study. We couldn’t have done it without all of you!
Human Paratuberculosis Foundation is dedicated to providing the most up-to-date information in our field to assist patients around the world in making informed decisions about their treatment. We are grateful for the support of this community and look forward to taking this journey together.
Read all the latest news and research about Mycobacterium avium subsp. paratuberculosis (MAP) and the treatment of Crohn’s and other diseases using AMAT and other therapies. Enjoy!